as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹654.9
Change
+0.65 (0.1%)
Open
₹658.0
Prev. Close
₹654.25
Day High
₹661.1
Day Low
₹652.0
Volume Analysis
Traded
122,436
Delivered
89,727
Delivery %
73.28%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (1)
- •Trading within 3% of its 52-week low (₹645.0)
Opportunities (2)
- •Strong 3-year EPS growth (63.7%)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹669.1 | ₹665.1 | ₹660.0 | ₹656.0 | ₹650.9 | ₹646.9 | ₹641.8 |
| Fibonacci | ₹665.1 | ₹661.62 | ₹659.48 | ₹656.0 | ₹652.52 | ₹650.38 | ₹646.9 |
| Camarilla | ₹657.4 | ₹656.57 | ₹655.73 | ₹656.0 | ₹654.07 | ₹653.23 | ₹652.4 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-19.21%
1 Week
-0.88%
1 Month
-3.17%
3 Months
-19.22%
6 Months
-20.9%
1 Year
-16.77%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹260.65
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
10.1%
Net margin 2.9% × asset turnover 1.75x × equity multiplier 1.99x
Company Overview
Sector
Consumer Services
Market Cap
₹7,868 Cr
P/E (TTM)
37.4
ROE
11.6%
Book Value
₹165.0
Face Value
₹2.0
Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.
TopFund Analysis
Medplus Health Serv Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Consumer Services sector, at 57/100. The strongest factor is Risk & Volatility (86/100), while Momentum (3/100) is the weakest area to weigh before deciding. Notably: Trading within 3% of its 52-week low (₹645.0). Strong 3-year EPS growth (63.7%).
TopFund Score — Fundamentals Quality
57/100 — AverageData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has delivered good profit growth of 28.2% CAGR over last 5 years
- −Stock is trading at 3.98 times its book value
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company has a low return on equity of 8.35% over last 3 years.
- −Promoters have pledged 60.7% of their holding.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Board comments on Regulation 17(1A) non-compliance and exchange fine; shareholder approval obtained on 17 August 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,284 | 1,409 | 1,441 | 1,490 | 1,489 | 1,576 | 1,561 | 1,510 | 1,543 | 1,679 | 1,806 | 1,864 | 1,880 |
| Expenses + | 1,213 | 1,324 | 1,350 | 1,385 | 1,395 | 1,452 | 1,429 | 1,373 | 1,412 | 1,530 | 1,648 | 1,695 | 1,746 |
| Operating Profit | 71 | 85 | 92 | 106 | 94 | 124 | 133 | 136 | 131 | 149 | 159 | 169 | 133 |
| OPM % | 6.0% | 6.0% | 6.0% | 7.0% | 6.0% | 8.0% | 8.0% | 9.0% | 8.0% | 9.0% | 9.0% | 9.0% | 7.0% |
| Other Income + | 9 | 10 | 10 | 10 | 9 | 12 | 13 | 16 | 15 | 17 | 18 | 21 | 20 |
| Interest | 23 | 24 | 24 | 25 | 25 | 25 | 26 | 27 | 27 | 29 | 31 | 33 | 33 |
| Depreciation | 52 | 55 | 57 | 59 | 60 | 63 | 62 | 64 | 66 | 69 | 73 | 76 | 78 |
| Profit before tax | 5 | 16 | 20 | 32 | 18 | 48 | 57 | 61 | 53 | 69 | 73 | 80 | 42 |
| Tax % | 26.0% | 12.0% | 31.0% | -5.0% | 19.0% | 19.0% | 19.0% | 16.0% | 20.0% | 19.0% | 21.0% | 20.0% | 21.0% |
| Net Profit + | 4 | 15 | 14 | 34 | 14 | 39 | 46 | 51 | 42 | 56 | 58 | 64 | 33 |
| EPS in Rs | 0 | 1 | 1 | 3 | 1 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 3 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,368 | 1,733 | 2,011 | 2,131 | 2,273 | 2,871 | 3,069 | 3,779 | 4,558 | 5,625 | 6,136 | 6,892 | 7,229 |
| Expenses + | 1,336 | 1,696 | 1,940 | 2,073 | 2,153 | 2,737 | 2,852 | 3,507 | 4,292 | 5,270 | 5,648 | 6,284 | 6,620 |
| Operating Profit | 32 | 37 | 71 | 58 | 120 | 134 | 217 | 273 | 266 | 355 | 488 | 608 | 610 |
| OPM % | 2.4% | 2.1% | 3.5% | 2.7% | 5.0% | 4.7% | 7.0% | 7.0% | 6.0% | 6.0% | 8.0% | 9.0% | 8.0% |
| Other Income + | 4 | 8 | 7 | 8 | 11 | 17 | 21 | 31 | 46 | 40 | 48 | 71 | 76 |
| Interest | 14 | 17 | 19 | 28 | 50 | 47 | 55 | 66 | 83 | 96 | 103 | 120 | 126 |
| Depreciation | 9 | 10 | 11 | 12 | 59 | 75 | 88 | 119 | 182 | 224 | 250 | 283 | 295 |
| Profit before tax | 14 | 19 | 48 | 26 | 23 | 29 | 95 | 118 | 47 | 73 | 183 | 275 | 264 |
| Tax % | 46.0% | 52.0% | 40.0% | -65.0% | 48.0% | 94.0% | 34.0% | 20.0% | -6.0% | 11.0% | 18.0% | 20.0% | — |
| Net Profit + | 7 | 9 | 29 | 42 | 12 | 2 | 63 | 95 | 50 | 66 | 150 | 220 | 210 |
| EPS in Rs | 419 | 509 | 1,621 | 2,080 | 585 | 107 | 1,393 | 8 | 4 | 5 | 13 | 18 | 18 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 141 | 137 | 148 | 303 | 291 | 528 | 730 | 1,394 | 1,467 | 1,554 | 1,717 | 1,951 |
| Borrowings + | 170 | 223 | 204 | 162 | 429 | 477 | 590 | 815 | 900 | 1,010 | 1,120 | 1,424 |
| Other Liabilities + | 126 | 149 | 183 | 179 | 239 | 344 | 245 | 361 | 406 | 417 | 500 | 533 |
| Total Liabilities | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 | 3,360 | 3,933 |
| Fixed Assets + | 67 | 77 | 81 | 83 | 377 | 419 | 517 | 799 | 1,138 | 1,242 | 1,296 | 1,595 |
| CWIP | 3 | 3 | 2 | 1 | 1 | 5 | 6 | 20 | 25 | 11 | 16 | 32 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 368 | 429 | 453 | 560 | 580 | 924 | 1,043 | 1,775 | 1,633 | 1,752 | 2,047 | 2,306 |
| Total Assets | 438 | 509 | 535 | 644 | 959 | 1,349 | 1,566 | 2,594 | 2,797 | 3,005 | 3,360 | 3,933 |
| Equity Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24 | 24 | 24 | 24 | 24 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -19 | -17 | 34 | 32 | 147 | -7 | 3 | 170 | 90 | 144 | 540 | 496 |
| Cash from Investing Activity + | -16 | -32 | -15 | -18 | -19 | -28 | -35 | -703 | 429 | -83 | -318 | -128 |
| Cash from Financing Activity + | 67 | 35 | -29 | -1 | -83 | 90 | -6 | 440 | -170 | -198 | -228 | -256 |
| Net Cash Flow | 32 | -15 | -10 | 14 | 45 | 56 | -37 | -93 | 350 | -137 | -5 | 112 |
| CFO/OP | -26 | -19 | 70 | 96 | 133 | 6 | 15 | 75 | 39 | 49 | 120 | 94 |
| Free Cash Flow | -35 | -35 | 19 | 32 | 125 | -37 | -51 | 56 | -78 | 61 | 482 | 373 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Others | 0.12% | 0.1% | 0.1% | 0.08% | 0.07% | 0.05% | 0.05% | 0.05% | 0.05% | 0.04% | 0.04% | 0.04% |
| Public | 21.61% | 21.31% | 22.1% | 22.51% | 16.85% | 18.68% | 17.82% | 17.18% | 16.6% | 16.27% | 16.41% | 15.45% |
| Promoters | 40.41% | 40.45% | 40.39% | 40.39% | 40.39% | 40.39% | 40.33% | 40.32% | 40.29% | 40.29% | 40.22% | 40.19% |
| FII | 12.36% | 12.96% | 14.94% | 14.85% | 14.72% | 15.23% | 15.61% | 16.43% | 16.53% | 16.83% | 15.53% | 14.38% |
| DII | 25.5% | 25.19% | 22.47% | 22.17% | 27.98% | 25.66% | 26.19% | 26.03% | 26.51% | 26.58% | 27.82% | 29.95% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Consumer Services — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Medplus Health Serv Ltd (this stock) | 7,868 | 37.4 | 3.97 | 11.6% |
| V2 Retail Limited | 7,830 | 49.4 | 8.67 | 22.9% |
| Entero Healthcare Solu L | 8,019 | 62.1 | 4.75 | 6.94% |
| Waterways Leisure Tour L | 7,617 | 190.0 | — | 92.3% |
| Electronics Mart Ind Ltd | 7,361 | 37.5 | 4.52 | 6.24% |
| Lemon Tree Hotels Ltd | 8,403 | 32.8 | 6.02 | 19.2% |
| Sapphire Foods India Ltd | 7,186 | 2920.0 | 5.17 | -1.03% |
Which Mutual Funds Hold Medplus Health Serv Ltd?
Frequently Asked Questions about Medplus Health Serv Ltd
Medplus Health Serv Ltd (MEDPLUS) closed at ₹654.9 on NSE on 25 September 2026, up 0.65 (0.1%) from the previous close.
Medplus Health Serv Ltd trades on the NSE (National Stock Exchange of India) under the symbol MEDPLUS.
Medplus Health Serv Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 37.4.
Medplus Health Serv Ltd has a dividend yield of 0.0%.
Medplus Health Serv Ltd's 52-week high is ₹1,022.0 and its 52-week low is ₹645.0.
Medplus Health Serv Ltd has a market capitalisation of ₹7,868 crore.
Medplus Health Serv Ltd has a TopFund Quality Score of 57/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Medplus Health Serv Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.